Abstract：Objective To investigate the factors that influence the short-term (6 months) prognosis in children with acute liver failure. Methods The clinical information of 53 children with acute liver failure treated between June 2008 and September 2013 was retrospectively analyzed. The patients were divided into survival group (n=21) and death group (n=32) according to their outcomes. The liver function parameters and incidence of complications were compared between the two groups, and multivariate logistic regression analysis was used to identify major factors affecting the short-term prognosis in these patients. Results There were significant differences between the death and survival groups in the indices of international normalized ratio (INR), blood ammonia and serum albumin (Alb), and complications such as hepatic encephalopathy, gastrointestinal hemorrhage, and multiple organ failure (POR=0.616, 75.493 and 1210.727 respectively; PConclusions INR, hepatic encephalopathy and serum Alb are the major factors that influence the short-term prognosis in children with acute liver failure.
Sharandeep K, Praveen K, Virendra K, eT al. ETiology and prognosTic facTors of acuTe liver failure in children [J]. Indian PediaTr, 2013, 50(7): 677-679.
[2]
RoberT HS, Benjamin LS, John B, eT al. AcuTe liver failure in children: The firsT 348 paTienTs in The pediaTric acuTe liver failure sTudy group [J]. J PediaTr, 2006, 148(5): 652-658.
[3]
Willars C. UpdaTe in inTensive care medicine: acuTe liver failure. IniTial managemenT, supporTive TreaTmenT and who ToTransplanT[J]. Curr Opin CriT Care, 2014, 20(2): 202-209.
[4]
RoberT S. AcuTe liver failure in children[J]. Semin Liver Dis, 2008, 28( 2): 153-166.
Poddar B, Saigal S, Kumar A, eT al. FacTors associaTed wiTh ouTcome in acuTe liver failure in an inTensive care uniT [J]. Indian J GasTroenTerol, 2013, 32(3): 172-178.
[7]
Munoz SJ, STraviTz RT, Gabriel DA. CoagulopaThy of acuTe liver failure[J]. Clin Liver Disease, 2009, 13(1): 95-107.
JonaThan PS, Debbie LS. RecenT insighTs inTo The paThogenesis of hepaTic encephalopaThy and TreaTmenTs[J]. ExperT Rev GasTroenTerol HepaTol, 2014, 8(1): 83-100.
[10]
Agarwal B, WrighT G, GaTT A, eT al. EvaluaTion of coagulaTion abnormaliTies in acuTe liver failure.[J]. J HepaTol, 2012, 54(4): 780-786.
[11]
AmaThieu R, Levesque E, Merle JC, eT al. Severe Toxic acuTe liver failure: eTiology and TreaTmenT[J]. Ann Fr AnesTh Reanim, 2013, 32(6): 416-421.
STauber RE, Spindelboeck W, Haas J, eT al. Human nonmercapTalbumin-2: a novel prognosTic marker in chronic liver failure[J]. Ther Apher Dial, 2014, 18(1): 74-78.
[15]
ChanTal B, Roger FB. Liver-brain proinflammaTory signalling in acuTe liver failure: role in The paThogenesis of hepaTic encephalopaThy and brain edema[J]. MeTabolic Brain Disease, 2013, 28(2):145-150.
[16]
Elinav E, Ben-Dov I, Hai-Am E, eT al. The predicTive value of admission and follow up facTor V and VII levels in paTienTs wiTh acuTe hepaTiTis and coagulopaThy[J]. J HepaTol, 2005, 42(1): 82-86.
[17]
FicheT J, Mercier E, Genée O, eT al. Prognosis and 1-year morTaliTy of inTensive care uniT paTienTs wiTh severe hepaTic encephalopaThy[J]. J CriT Care, 2009, 24(3): 364-370.
[18]
O'Grady J. Timing and benefiT of liver TransplanTaTion in acuTe liver failure[J]. J HepaTol, 2014, 60(3): 663-670.
[19]
Lee WM, Squires RH Jr, Nyberg SL, eT al. AcuTe liver failure: Summary of a workshop[J]. HepaTology, 2008, 47(4): 1401-1415.
